Early Metabolic Response Evaluation by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Allows In vivo Testing of Chemosensitivity in Gastric Cancer: Long-term Results of a Prospective Study

Purpose: We prospectively evaluated the predictive value of positron emission tomography using fluorine-18 fluorodeoxyglucose (FDG-PET) for in vivo testing of chemosensitivity in locally advanced gastric cancer using an a priori definition of metabolic response (a decrease of >35% of the standard...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical cancer research 2008-04, Vol.14 (7), p.2012-2018
Hauptverfasser:	OTT, Katja, HERRMANN, Ken, SCHUSTER, Tibor, SCHWAIGER, Markus, SIEWERT, Jörg-Rüdiger, KRAUSE, Bernd J, LORDICK, Florian, WIEDER, Hinrich, WEBER, Wolfgang A, BECKER, Karen, BUCK, Andreas K, DOBRITZ, Martin, FINK, Ulrich, ULM, Kurt
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Drug Resistance, Neoplasm FDG-PET Female Fluorodeoxyglucose F18 - metabolism gastric cancer Gastroenterology. Liver. Pancreas. Abdomen Humans Kaplan-Meier Estimate Male Medical sciences Middle Aged Pharmacology. Drug treatments Positron-Emission Tomography Predictive Value of Tests Prognosis Prospective Studies Radiopharmaceuticals - metabolism response prediction Stomach Neoplasms - diagnostic imaging Stomach Neoplasms - drug therapy Stomach Neoplasms - mortality Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Time Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!